BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17070600)

  • 1. Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock.
    Rajagopalan G; Smart MK; Murali N; Patel R; David CS
    J Reprod Immunol; 2007 Feb; 73(1):51-9. PubMed ID: 17070600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response.
    Rajagopalan G; Sen MM; Singh M; Murali NS; Nath KA; Iijima K; Kita H; Leontovich AA; Gopinathan U; Patel R; David CS
    Shock; 2006 Jun; 25(6):647-56. PubMed ID: 16721274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
    Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
    Yeung RS; Penninger JM; Kündig T; Khoo W; Ohashi PS; Kroemer G; Mak TW
    Eur J Immunol; 1996 May; 26(5):1074-82. PubMed ID: 8647170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock.
    Ferry T; Thomas D; Perpoint T; Lina G; Monneret G; Mohammedi I; Chidiac C; Peyramond D; Vandenesch F; Etienne J
    Clin Microbiol Infect; 2008 Jun; 14(6):546-54. PubMed ID: 18373692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
    Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
    Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T; Wahl C; Heeg K; Wagner H
    J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
    Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
    J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical timing, location and duration of glucocorticoid administration rescue mice from superantigen-induced shock and attenuate lung injury.
    Krakauer T; Buckley MJ; Huzella LM; Alves DA
    Int Immunopharmacol; 2009 Sep; 9(10):1168-74. PubMed ID: 19539058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of acute inflammatory lung injury by staphylococcal enterotoxin B.
    Neumann B; Engelhardt B; Wagner H; Holzmann B
    J Immunol; 1997 Feb; 158(4):1862-71. PubMed ID: 9029127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
    De Boer ML; Kum WW; Chow AW
    Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.
    Karau MJ; Tilahun ME; Krogman A; Osborne BA; Goldsby RA; David CS; Mandrekar JN; Patel R; Rajagopalan G
    Virulence; 2017 Oct; 8(7):1148-1159. PubMed ID: 27925510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.
    Uchiyama T; Kamagata Y; Yan XJ; Kawachi A; Fujikawa H; Igarashi H; Okubo M
    Clin Exp Immunol; 1989 Feb; 75(2):239-44. PubMed ID: 2784735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock.
    Krakauer T; Buckley M
    Antimicrob Agents Chemother; 2006 Jan; 50(1):391-5. PubMed ID: 16377721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of interstitial pneumonia in autoimmune mice by intratracheal administration of superantigen staphylococcal enterotoxin B.
    Shinbori T; Matsuki M; Suga M; Kakimoto K; Ando M
    Cell Immunol; 1996 Dec; 174(2):129-37. PubMed ID: 8954612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
    Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
    Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purpura fulminans due to Staphylococcus aureus.
    Kravitz GR; Dries DJ; Peterson ML; Schlievert PM
    Clin Infect Dis; 2005 Apr; 40(7):941-7. PubMed ID: 15824983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase 2 pathway and its therapeutic inhibition in superantigen-induced toxic shock.
    Rajagopalan G; Asmann YW; Lytle AK; Tilahun AY; Theuer JE; Smart MK; Patel R; David CS
    Shock; 2008 Dec; 30(6):721-8. PubMed ID: 18496243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutics targeting immune activation by staphylococcal superantigens.
    Krakauer T
    Med Sci Monit; 2005 Sep; 11(9):RA290-5. PubMed ID: 16127375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.